Literature DB >> 11702314

Management of seborrheic dermatitis and pityriasis versicolor.

J Faergemann1.   

Abstract

Pityriasis (tinea) versicolor and seborrheic dermatitis are two very common skin diseases. Pityriasis versicolor is a chronic superficial fungal disease usually located on the upper trunk, neck, or upper arms. In pityriasis versicolor, the lipophilic yeast Malassezia (also know as Pityrosporum ovale or P. orbiculare) changes from the blastospore form to the mycelial form under the influence of predisposing factors. The most important exogenous factors are high temperatures and a high relative humidity which probably explain why pityriasis versicolor is more common in the tropics. The most important endogenous factors are greasy skin, hyperhidrosis, hereditary factors, corticosteroid treatment and immunodeficiency. There are many ways of treating pityriasis versicolor topically. Options include propylene glycol, ketoconazole shampoo, zinc pyrithione shampoo, ciclopiroxamine, selenium sulfide, and topical antifungals. In difficult cases, short term treatment with fluconazole or itraconazole is effective and well tolerated. To avoid recurrence a prophylactic treatment regimen is mandatory. Seborrheic dermatitis is characterized by red scaly lesions predominantly located on the scalp, face and upper trunk. There are now many studies indicating that Malassezia plays an important role in this condition. Even a normal number of Malassezia will start an inflammatory reaction. Mild corticosteroids are effective in the treatment of seborrheic dermatitis. However, the disease recurs quickly, often within just a few days. Antifungal therapy is effective in the treatment of seborrheic dermatitis and, because it reduces the number of Malassezia, the time to recurrence is increased compared with treatment with corticosteroids. Antifungal therapy should be the primary treatment of this disease.

Entities:  

Mesh:

Year:  2000        PMID: 11702314     DOI: 10.2165/00128071-200001020-00001

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  19 in total

1.  Calcineurin is required for Candida albicans to survive calcium stress in serum.

Authors:  Jill R Blankenship; Joseph Heitman
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Rotundiform morphology during the first episode of pityriasis versicolor - a retrospective case-control study on a distinct clinical presentation.

Authors:  Vijay Zawar; Antonio Chuh; Sudhir Sankalecha
Journal:  J Dermatol Case Rep       Date:  2007-12-29

3.  Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).

Authors:  Lorena Dantas; Eduardo Netto; Marshall J Glesby; Edgar M Carvalho; Paulo Machado
Journal:  Int J Dermatol       Date:  2013-09-30       Impact factor: 2.736

Review 4.  Fungi on the skin: dermatophytes and Malassezia.

Authors:  Theodore C White; Keisha Findley; Thomas L Dawson; Annika Scheynius; Teun Boekhout; Christina A Cuomo; Jun Xu; Charles W Saunders
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915

Review 5.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Optimizing treatment approaches in seborrheic dermatitis.

Authors:  Goldenberg Gary
Journal:  J Clin Aesthet Dermatol       Date:  2013-02

7.  Topical pimecrolimus 1% cream in the treatment of seborrheic dermatitis.

Authors:  Grace K Kim; James Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2013-02

Review 8.  Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.

Authors:  Jamie D Croxtall; Greg L Plosker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Treatment of facial seborrheic dermatitis with pimecrolimus cream 1%: an open-label clinical study in Korean patients.

Authors:  Byung-Soo Kim; Su-Han Kim; Moon-Bum Kim; Chang-Keun Oh; Ho-Sun Jang; Kyung-Sool Kwon
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

10.  Randomized comparative clinical trial of Artemisia sieberi 5% lotion and clotrimazole 1% lotion for the treatment of pityriasis versicolor.

Authors:  Farrokh Rad; Farzad Aala; Naser Reshadmanesh; Rokshana Yaghmaie
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.